Representative Matters
代表事项
REFERENZMANDATE
- Represented fintech software platform in $4 million asset sale to private fintech company
- Represented Compass Therapeutics in $60 million acquisition of TRIGR Therapeutics
- Represented Salsify in acquisition of Alkemics
- Represented Pitango Venture Capital, Evergreen Venture Partners and Fidelity Management & Research Company LLC in the acquisition of Taboola by Ion Acquisition Corp. 1 Ltd.
- Represented Bessemer Venture Partners in the acquisition of Otonomo Technologies by Software Acquisition Group Inc. II
- Represented TriNetX in sale of majority stake to The Carlyle Group
- Represented Stella Connect in sale to Medallia
- Represented Checkmate Pharmaceuticals, Inc. in initial public offering
- Represented private equity company in $42 million acquisition of market research company
- Represented Mobeewave in $115 million stock sale to Apple
- Represented market research company in $30 million sale to private equity company
- Represented Iconics in sale to Mitsubishi Electric
- Represented Flywheel in sale to WP Engine
- Represented StellaService in asset sale to PowerReviews and $11 million Series B financing by Harbert Growth Partners and Zendesk
- Represented Kyn Therapeutics in stock-for-stock acquisition of Arrys Therapeutics
- Represented Qualtrics in $8 billion sale to SAP
- Represented biotech in $750 million sale to public pharmaceutical company*
- Represented biotech in $400 million sale to foreign pharmaceutical company*
- Represented public energy company in $220 million acquisition of foreign energy company*
- Represented venture capital fund in $48 million acquisition of renewable energy company*
- Represented private equity fund in $52 million acquisition of healthcare services company*
- Represented venture capital fund in $55 million acquisition of renewable energy company*
- Represented venture capital fund in $42 million sale of waste management company*
- Represented private hospital in $115 million sale to private health system*
- Represented medical device company in $21 million sale to a private medical device manufacturer*
- Represented private equity fund in $16.3 million acquisition of component manufacturing company*
* Denotes experience prior to joining Goodwin.
- Represented consortium of investors in $10.4 million bridge financing of private fintech company
- Represented consortium led by Novastar, FMO and Global Ventures in Series B financing of TeamApt
- Represented Klaviyo in $320 million Series D financing by consortium led by Sands Capital
- Represented Sanergy, Inc. in a Series B-2 financing led by AXA IM and a $2.55 million bridge debt facility by consortium led by Novastar and Acumen
- Represented private telehealth company in $2 million convertible note financing by various venture capital investors
- Represented Stavvy in $40 million Series A financing by Morningside Technology Ventures
- Represented Novastar Ventures in $2 million Series A financing of Turaco
- Represented BeiGene in financing of private biotech company
- Represented MBX Biosciences in $34.6 million Series A financing by Frasier, OrbiMed and NEA
- Represented Komaza, Inc. in $28 million Series B financing led by AXA, FMO and Novastar
- Represented Checkmate Pharmaceuticals in $85 million Series C financing by consortium led by Longitude and Novo
- Represented Novastar Ventures as lead investor in $21.5 million Series C financing of mPharma Data
- Represented syndicate of investors in $5.5 million Series A financing of STP Investment Services
- Represented Sanergy, Inc. in $5 million debt financing by the Overseas Private Investment Corporation
- Represented OZÉ, Inc. in $1 million convertible note financing
- Represented Gokada Inc. in a $5.3 million Series A financing led by Rise Capital
- Represented fintech issuer in $2 million Series Seed financing
- Represented telehealth issuer in $2.1 million Seed financing
- Represented proptech issuer in $2 million Seed financing
- Represented Kyn Therapeutics in $15 million Series A-1 financing by Celgene Corporation
- Represented Checkmate Pharmaceuticals in $90 million Series B financing by Sofinnova, venBio, F-Prime and Decheng Capital
- Represented venture fund in $50 million investment in cell therapy company
- Represented biotech issuer in $300 million convertible limited recourse “synthetic” note financing, $200 million Series DD financing and $75 million equipment finance facility*
- Represented biotech issuer in $25 million Series A financing*
- Represented biotech issuer in $23 million recapitalization and financing*
- Represented venture fund in multiple transactions including $18 million investment in online* retailer, $7.5 million investment in merchant services provider and $5 million investment in mobile app developer*
- Represented venture fund in multiple transactions including $110 million recapitalization of waste management issuer, $30 million investment in energy storage issuer and $20 million in a renewable energy issuer*
- Represented venture fund in multiple transactions including $10 million investment in heating technology company, $12 million investment in insulation technology company and $20 million investment in cathode materials company*
- Represented online gaming issuer in $18.8 million Series B financing, secondary sale of founder shares*
- Represented wastewater treatment issuer in $12 million Series B financing, secondary sale of founder shares*
- Represented waste management issuer in $5 million Series B, $2 million Series A-2 and $2 million Series A financings, multiple bridge debt financings, $5 million OPIC loan and $2 million grant award from major foundation*
* Denotes experience prior to joining Goodwin.
Ms. Gerber is a member of the American and Boston Bar Associations, the Global Impact Investing Network, the Impact Investing Legal Working Group and the Boston chapter of Women in Technology International. She has also served as a mentor for the MIT $100K Business Plan Competition, Cleantech Open Northeast, Boston College’s Soaring Startup Circle and the Hult Prize Competition and has been a guest lecturer at Boston College Law School.
Prior to joining Goodwin, Ms. Gerber practiced as an associate at prominent Boston-based international law firms. She has also served as a judicial intern to the Honorable Chief Judge Joseph Bataillon in the United States District Court for the District of Nebraska and worked as a corporate auditor for the Union Pacific Corporation.